Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria

Clinical and Experimental Immunology

Volumn 166, Issue 2, 2011, Pages 218-226

  Ayimba, E ^a,c   Hegewald, J ^c,e   Segbena A Y ^a   Gantin, R G ^a,c   Lechner, C J ^c,e   Agosssou, A ^c,d   Banla, M ^b,c   Soboslay, P T ^c,e  

^a UNIVERSITY OF LOMÉ   (Togo)

^b UNIVERSITÉ DE LOMÉ   (Togo)

^c Institut National d'Hygiène Onchocerciasis Reference Laboratory   (Togo)

^d Service Pédiatrie Centre Hospitalier Régional   (Togo)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Chemokine; Cytokine; Infant; Infection; Malaria; Plasmodium falciparum

Indexed keywords

CHEMOKINE; CXCL16 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 27; INTERLEUKIN 31; INTERLEUKIN 33; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ARTICLE; BRAIN TISSUE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSURVEILLANCE; INFANT; INFECTION CONTROL; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION;

CENTRAL NERVOUS SYSTEM; CHEMOKINES; CHILD, PRESCHOOL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION MEDIATORS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM;

EID: 80053619549     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04474.x     Document Type: Article

References (68)

1. Clark IA, Budd AC, Alleva LM etal. Human malarial disease: a consequence of inflammatory cytokine release. Malar J 2006; 5:85-117.
2. Clark IA, Alleva LM, Mills AC etal. Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 2004; 17:509-39.
3. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14:129-35.
4. Sharma M, Vohra H, Bhasin D. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica: a basis of invasive disease. Parasitology 2005; 131:783-96.
5. Benevides L, Milanezi CM, Yamauchi LM etal. CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system. Am J Pathol 2008; 173:741-51.
6. Sharma M, Bhasin D, Vohra H. Differential induction of immunoregulatory circuits of phagocytic cells by Gal/Gal NAc lectin from pathogenic and nonpathogenic Entamoeba. Clin Immunol 2008; 28:542-57.
7. Roffe E, Oliviera F, Souza AL etal. Role of CCL3/MIP-1alpha and CCL5/Rantes during acute Trypanosoma cruzi infection in rats. Microbes Infect 2010; 12:669-76.
8. Oghumu S, Lezama-Dávila CM, Isaac-Márquez AP etal. Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol 2010; 126:389-96.
9. Ochiel DO, Awandara GA, Keller CC etal. Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria. Infect Immun 2005; 73:4190-7.
10. Perlmann P, Perlmann H, ElGhazali G, Blomberg MT. IgE and tumor necrosis factor in malaria infection. Immunol Lett 1999; 65:29-33.
11. Perlmann P, Troye-Blomberg M. Malaria blood-stage infection and its control by the immune system. Folia Biol (Praha) 2000; 46:210-18.
12. Torre D, Giola M, Speranza F, Matteelli A, Basilico C, Biondi G. Serum levels of interleukin-18 in patients with uncomplicated Plasmodium falciparum malaria. Eur Cytokine Netw 2001; 12:361-4.
13. Lyke KE, Burges R, Cissoko Y etal. Serum levels of the pro-inflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 2004; 72:5630-7.
14. Luty AJ, Perkins DJ, Lell B etal. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 2000; 68:3909-15.
15. Armah HB, Wilson NO, Sarfo BY etal. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J 2007; 6:147-64.
16. Druilhe P, Pérignon JL. Mechanisms of defense against P. falciparum asexual blood stages in humans. Immunol Lett 1994; 41:115-20.
17. Stanisic DI, Richards JS, McCallum FJ etal. Imunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun 2009; 77:1165-74.
18. Roussilhon C, Oeuvray C, Müller-Graf C etal. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med 2007; 4:e320.
19. Good MF, Xu H, Wykes M, Engwerda CR. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol 2005; 23:69-99.
20. Schofield L. Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunol Cell Biol 2007; 85:130-7.
21. Malhotra I, Mungai P, Muchiri E etal. Distinct Th1- and Th2-type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun 2005; 73:3462-70.
22. Kirch AK, Agossou A, Banla M etal. Parasite-specific antibody and cytokine profiles in newborns from Plasmodium falciparum- and Entamoeba histolytica/dispar-infected mothers. Pediatr Allergy Immunol 2004; 15:133-41.
23. Kocherscheidt L, Agossou A, Gantin R etal. Cytokine and chemokine responses in adults newborns and children exposed to Entamoeba histolytica/Entamoeba dispar, Onchocerca volvulus and Plasmodium falciparum. Pediatr Allergy Immunol 2010; 21:e756-63.
24. Luty AJ, Lell B, Schmidt-Ott R etal. Parasite antigen-specific interleukin-10 and antibody responses predict accelerated parasite clearance in Plasmodium falciparum malaria. Eur Cytokine Netw 1998; 9:639-46.
25. Wipasa J, Okell L, Sakkhachornphop S etal. Short lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog 2011; 7:e1001281.
26. Brustoski K, Möller U, Kramer M etal. IFN-γ and IL-10 mediate parasite-specific immune responses of cord blood cells induced by pregnancy-associated Plasmodium falciparum malaria. J Immunol 2005; 1:1738-45.
27. Broen K, Brustoski K, Engelmann I etal. Placental Plasmodium falciparum infection: causes and consequences of in utero sensitization to parasite antigens. Mol Biochem Parasitol 2007; 151:1-8.
28. Soboslay PT, Geiger SM, Drabner B etal. Prenatal immune priming in onchocerciasis -Onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers. Clin Exp Immunol 1999; 117:130-7.
29. Mirghani HA, Eltahir HG, A-Elgadir TM etal. Cytokine profiles in children with severe Plasmodium falciparum malaria in an area of unstable malaria transmission in central Sudan. J Trop Pediatr 2010; 30 November. [Epub ahead of print].
30. Kurtzhals JA, Adabayeri V, Goka BQ etal. Low plasma concentrations of interleukin 10 in severe malarial anemia compared with cerebral and uncomplicated malaria. Lancet 1998; 351:1768-72.
31. Sinha S, Qidwai T, Kanchan K etal. Distinct cytokine profiles define clinical immune response to falciparum malaria in regions of high or low disease transmission. Eur Cytokine Netw 2010; 21:232-40.
32. Hugosson E, Montgomery SM, Premji Z etal. Relationship between antipyretics effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes. Acta Trop 2006; 99:77-82.
33. Muchamuel T, Menon S, Pisacan P etal. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-α, IFN-γ, and IL-12 production. J Immunol 1997; 158:2896-903.
34. Berry A, Balard P, Costa A etal. IL-13 induces expression of CD36 in human monocytes through PPAR-gamma activation. Eur J Immunol 2007; 37:1642-52.
35. Ohashi J, Naka I, Patarapotikul J etal. A single nucleotide substitution from C to T at position -1055 in the IL-13 promoter is associated with protection from severe malaria in Thailand. Genes Immun 2003; 4:528-31.
36. Murugaiyan G, Mittal A, Lopez-Diego R, Maier LM, Anderson DE, Weiner HL. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 2009; 183:2435-43.
37. Sturmhofer SJ, Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008; 117:123-30.
38. Hunter CA, Villarino A, Artis D, Scott P. The role of IL-27 in the development of T-cell responses during parasitic infections. Immunol Rev 2004; 202:106-14.
39. Bancroft AJ, Humphreys NE, Worthington JJ, Yoshida H, Grencis RK. WSX-1: a key role in induction of chronic intestinal nematode infection. J Immunol 2004; 172:7635-41.
40. Findlay EG, Greig R, Stumhofer JS etal. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J Immunol 2010; 185:2482-92.
41. Korn T, Bettelli E, Oukka M etal. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27:485-517.
42. Kebir H, Kreymborg K, Ifergan I etal. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007; 13:1173-75.
43. Ishida H, Matsuzaki-Moriya C, Imai T etal. Development of experimental cerebral malaria is independent of IL-23 and IL-17. Biochem Biophys Res Commun 2010; 402:790-5.
44. Yagi Y, Andoh A, Nishida A etal. Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts. Int J Mol Med 2007; 19:941-6.
45. Heinrich PC, Behrmann I, Muller-Newen G etal. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998; 334:297-314.
46. Zhang Q, Puthetib P, Zhoub Q, Liua Q, Gaob W. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 2008; 19:347-56.
47. Dillon SR, Sprecher C, Hammond A etal. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5:752-60.
48. Perrigoue JG, Li J, Zaph C etal. IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J Exp Med 2007; 204:481-7.
49. Lei Z, Liu G, Huang Q etal. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 2008; 63:327-32.
50. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10:103-10.
51. Dinarello CA. An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity 2005; 23:461-2.
52. Humphreys NE, Xu D, Hepworth MR etal. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 2008; 180:2443-9.
53. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 2008; 3:e3331.
54. Schmitz J, Owyang A, Oldham E etal. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-90.
55. Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 2010; 59:143-60.
56. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003; 24:491-9.
57. Armah H, Dodoo AK, Wiredu EK etal. High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol 2005; 99:629-47.
58. Campanella GS, Tager AM, Houry JK etal. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA 2008; 105:4814-19.
59. Berthoud TK, Dunachie SJ, Todryk S, Hill AVS, Fletcher HA. MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines. J Immunol Methods 2009; 340:33-41.
60. Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan DJ. Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood 2009; 114:4243-52.
61. McKimmie CS, Graham GJ. Astrocytes modulate the chemokines network in a pathogen-specific manner. Biochem Biophys Res Commun 2010; 394:1006-11.
62. Fahy OL, Townley SL, Coates NJ, Clark-Lewis I, McColl SR. Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3alpha/CCL20. Lab Invest 2004; 84:1501-11.
63. Woehrl B, Klein M, Rupprecht TA etal. CXCL16 contributes to neutrophil recruitment to cerebrospinal fluid in pneumococcal meningitis. J Infect Dis 2010; 202:1389-96.
64. Alt C, Laschinger M, Engelhardt B. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunl 2002; 32:2133-44.
65. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 2006; 113:477-85.
66. Ploix CC, Noor S, Cran J etal. CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain Behav Immun 2011; 25:883-96.
67. Noor S, Habashy AS, Nance JP etal. CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect Immun 2010; 78:2257-63.
68. Unsoeld H, Mueller K, Schleicher U etal. Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections. Int Immunol 2007; 19:1281-9.